Manuel A. Friese
University of Hamburg
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Manuel A. Friese.
Nature | 2014
Theresa Schumacher; Lukas Bunse; Stefan Pusch; Felix Sahm; Benedikt Wiestler; Jasmin Quandt; Oliver Menn; Matthias Osswald; Iris Oezen; Martina Ott; Melanie Keil; Jörg Balß; Katharina J. Rauschenbach; Agnieszka K. Grabowska; Isabel Vogler; Jan Diekmann; Nico Trautwein; Stefan B. Eichmüller; Jürgen G. Okun; Stefan Stevanovic; Angelika B. Riemer; Ugur Sahin; Manuel A. Friese; Andreas von Deimling; Wolfgang Wick; Michael Platten
Monoallelic point mutations of isocitrate dehydrogenase type 1 (IDH1) are an early and defining event in the development of a subgroup of gliomas and other types of tumour. They almost uniformly occur in the critical arginine residue (Argu2009132) in the catalytic pocket, resulting in a neomorphic enzymatic function, production of the oncometabolite 2-hydroxyglutarate (2-HG), genomic hypermethylation, genetic instability and malignant transformation. More than 70% of diffuse grade II and grade III gliomas carry the most frequent mutation, IDH1(R132H) (ref. 3). From an immunological perspective, IDH1(R132H) represents a potential target for immunotherapy as it is a tumour-specific potential neoantigen with high uniformity and penetrance expressed in all tumour cells. Here we demonstrate that IDH1(R132H) contains an immunogenic epitope suitable for mutation-specific vaccination. Peptides encompassing the mutated region are presented on major histocompatibility complexes (MHC) class II and induce mutation-specific CD4+ T-helper-1 (TH1) responses. CD4+ TH1 cells and antibodies spontaneously occurring in patients with IDH1(R132H)-mutated gliomas specifically recognize IDH1(R132H). Peptide vaccination of mice devoid of mouse MHC and transgenic for human MHC class I and II with IDH1(R132H) p123-142 results in an effective MHC class II-restricted mutation-specific antitumour immune response and control of pre-established syngeneic IDH1(R132H)-expressing tumours in a CD4+ T-cell-dependent manner. As IDH1(R132H) is present in all tumour cells of these slow-growing gliomas, a mutation-specific anti-IDH1(R132H) vaccine may represent a viable novel therapeutic strategy for IDH1(R132H)-mutated tumours.
Blood | 2012
Mathias Gelderblom; Anna Weymar; Christian Bernreuther; Joachim Velden; Priyadharshini Arunachalam; Karin Steinbach; Ellen Orthey; Thiruma V. Arumugam; Frank Leypoldt; Olga Simova; Vivien Thom; Manuel A. Friese; Immo Prinz; Christoph Hölscher; Markus Glatzel; Thomas Korn; Christian Gerloff; Eva Tolosa; Tim Magnus
The devastating effect of ischemic stroke is attenuated in mice lacking conventional and unconventional T cells, suggesting that inflammation enhances tissue damage in cerebral ischemia. We explored the functional role of αβ and γδ T cells in a murine model of stroke and distinguished 2 different T cell-dependent proinflammatory pathways in ischemia-reperfusion injury. IFN-γ produced by CD4(+) T cells induced TNF-α production in macrophages, whereas IL-17A secreted by γδ T cells led to neutrophil recruitment. The synergistic effect of TNF-α and IL-17A on astrocytes resulted in enhanced secretion of CXCL-1, a neutrophil chemoattractant. Application of an IL-17A-blocking antibody within 3 hours after stroke induction decreased infarct size and improved neurologic outcome in the murine model. In autoptic brain tissue of patients who had a stroke, we detected IL-17A-positive lymphocytes, suggesting that this aspect of the inflammatory cascade is also relevant in the human brain. We propose that selective targeting of IL-17A signaling might provide a new therapeutic option for the treatment of stroke.
Journal of Reproductive Immunology | 2013
Konstantinos Patas; Jan Broder Engler; Manuel A. Friese; Stefan M. Gold
Multiple sclerosis (MS) is an inflammatory, demyelinating disease of the central nervous system of presumed autoimmune origin. Intriguingly, pregnancy in female MS patients is associated with a substantial decrease in relapse rate. However, post-partum the relapse rate increases in a rebounding fashion above the rate seen before pregnancy. Wide gaps remain in our understanding of the biological mechanisms underlying these pregnancy-related effects in MS patients. To date, most attempts to explain MS disease amelioration during pregnancy have focused on levels of circulating hormones with immunomodulatory properties such as estrogens and global shifts in systemic maternal immune cell composition. However, recent advances in our understanding of feto-maternal tolerance have provided evidence that fetal antigens directly interact with the maternal immune system. This results in specific immunomodulation such as fetal-antigen-dependent induction of regulatory T cells. Thus, the shaping of maternal immune responses by fetal antigens may represent an endogenous pathway by which antigen-specific immunomodulation might also contribute to reinstalling tolerance to autoantigens in MS. Reproductive immunology therefore has great potential to provide insights into MS immunopathogenesis and highlight novel avenues for treatment of MS and other autoimmune diseases.
Psychiatry Research-neuroimaging | 2013
Chi-un Choe; Evangelos Karamatskos; Benjamin Schattling; Frank Leypoldt; Gianpiero Liuzzi; Christian Gerloff; Manuel A. Friese; Christoph Mulert
Autoimmune encephalitis associated with IgG antibodies to the N-methyl-d-aspartic acid receptor subunit NR1 (NMDAR) presents with neurological symptoms, such as seizures, and especially psychiatric symptoms, such as hallucinations, psychosis, agitation and anxiety. To date, however, the pathological relevance of IgM NMDAR antibodies remains elusive. Here, we describe clinical, neuroradiological and neurobiological findings of a 28-year-old male presenting with IgM NMDAR antibodies coincident with autoimmune encephalitis characterized by symptoms of bipolar disorder. After repeated steroid treatment, cognitive and psychiatric abnormalities improved and no NMDAR antibody was detectable. Using primary neuronal cultures, we demonstrate that patients serum containing IgM NMDAR antibodies reduced the detection of NMDAR on neuronal cells and decreased cell survival. Although NMDAR encephalitis with IgG antibodies is increasingly recognized and diagnosed, atypical presentations with NMDAR antibodies with immunoglobulin subclasses other than IgG pose a diagnostic and therapeutic challenge. Further clinical and neurobiological studies are needed to study the pathophysiological relevance of IgM NMDAR antibodies.
Neuroscience & Biobehavioral Reviews | 2016
Caren Ramien; Aline Taenzer; Andreea Lupu; Nina Heckmann; Jan Broder Engler; Kostas Patas; Manuel A. Friese; Stefan M. Gold
Clinical observations in human autoimmune diseases such as multiple sclerosis (MS) suggest a pivotal role of sex-related factors in the etiopathogenesis. These include a female preponderance in MS incidence and an increasing sex bias over time, a parent-of-origin effect in MS inheritance, and the protective effect of pregnancy on disease activity. The complex interplay of factors contributing to these clinical phenomena, however, is incompletely understood and may include sex hormones as well as genetic or epigenetic sex differences. While genetic and hormonal effects are impossible to study independently in humans, novel mouse models have started to unravel the cause-effect relationship between individual sex-related factors and autoimmunity. Here, we present the evidence for mechanisms underlying sex differences in the immune system and the central nervous system (CNS) and how these might help to explain some of the clinically observed sex differences in MS. A better understanding of the molecular underpinnings may ultimately help to devise sex-specific treatment strategies as well as highlight novel avenues for therapy in both sexes.
Neurobiology of Disease | 2013
Mathias Gelderblom; Tristan Daehn; Benjamin Schattling; Peter Ludewig; Christian Bernreuther; Priyadharshini Arunachalam; Jakob Matschke; Markus Glatzel; Christian Gerloff; Manuel A. Friese; Tim Magnus
OBJECTIVEnWe aimed at validating a plasma biomarker for neuronal damage that can be used in acute and chronic models of neurological diseases.nnnMETHODSnWe investigated two different models, middle cerebral artery occlusion followed by reperfusion and MOG35-55-induced experimental autoimmune encephalomyelitis (EAE). In stroke experiments we measured infarct sizes by magnetic resonance imaging and vital stainings and correlated them with plasma levels of neuron specific enolase (NSE) at different time points after reperfusion. Equally, in EAE experiments, we correlated NSE levels with neurological scores and histopathological damage of axons at different time points. We detected plasma NSE levels by ELISA.nnnRESULTSnPlasma NSE levels correlated significantly with stroke size, EAE score and histopathological damage in EAE. Investigations into the dynamics of neuronal loss over time correlated well with the dynamics of NSE levels. NSE even predicted the onset of EAE, before clinical signs were recordable.nnnCONCLUSIONSnPlasma NSE is a valid and simple experimental biomarker that allows quantifying the degree of neuronal injury in a non-invasive approach.
Muscle & Nerve | 2011
Frank Leypoldt; Manuel A. Friese; Josef Böhm; Tobias Bäumer
Multiple nerve enlargements at non‐entrapment sites are usually caused by hereditary or acquired immune‐mediated neuropathies.We describe a case of multifocal hypertrophic mononeuropathies detected by nerve sonography with a clinical picture of progressive mononeuritis multiplex caused by a paraneoplastic syndrome associated with anti‐Hu antibodies. This case illustrates an unusual but important paraneoplastic differential diagnosis of progressive multifocal hypertrophic neuropathies. It emphasizes the role of nerve ultrasound in the diagnostic work‐up of peripheral nervous system disorders. Muscle Nerve, 2011
Neuroimmunology and Neuroinflammation | 2017
Sibylle Hodecker; Jan-Patrick Stellmann; Sina Cathérine Rosenkranz; Kim Lea Young; Brigitte Holst; Manuel A. Friese; Christoph Heesen
Neuromyelitis optica spectrum disorder (NMOSD) is a rare relapsing autoimmune demyelinating disease of the CNS that predominantly affects the optic nerves and the spinal cord.1 Because of the severity and poor recovery of attacks, aggressive immunosuppressive agents are used early in the clinical course to reduce relapse frequency. Apart from classical immunosuppressant agents, biologicals such as rituximab, eculizumab, or tocilizumab have been used for relapse prevention.2 Based on retrospective data, 17–53% of patients have break-through relapses under the most commonly used treatments azathioprine, mycophenolate mofetil, or rituximab.3
Nature microbiology | 2018
Stephanie Stanelle-Bertram; Kerstin Walendy-Gnirß; Thomas Speiseder; Swantje Thiele; Ivy Asantewaa Asante; Carola Dreier; Nancy Mounogou Kouassi; Annette Preuß; Gundula Pilnitz-Stolze; Ursula Müller; Stefanie Thanisch; Melanie Richter; Robin Scharrenberg; Vanessa Kraus; Ronja Dörk; Lynn Schau; Vanessa Herder; Ingo Gerhauser; Vanessa M. Pfankuche; Christopher Käufer; Inken Waltl; Thais Moraes; Julie Sellau; Stefan Hoenow; Jonas Schmidt-Chanasit; Stephanie Jansen; Benjamin Schattling; Harald Ittrich; Udo Bartsch; Thomas Renné
Congenital Zika virus (ZIKV) syndrome may cause fetal microcephaly in ~1% of affected newborns. Here, we investigate whether the majority of clinically inapparent newborns might suffer from long-term health impairments not readily visible at birth. Infection of immunocompetent pregnant mice with high-dose ZIKV caused severe offspring phenotypes, such as fetal death, as expected. By contrast, low-dose (LD) maternal ZIKV infection resulted in reduced fetal birth weight but no other obvious phenotypes. Male offspring born to LD ZIKV-infected mothers had increased testosterone (TST) levels and were less likely to survive in utero infection compared to their female littermates. Males also presented an increased number of immature neurons in apical and basal hippocampal dendrites, while female offspring had immature neurons in basal dendrites only. Moreover, male offspring with high but not very high (storm) TST levels were more likely to suffer from learning and memory impairments compared to females. Future studies are required to understand the impact of TST on neuropathological and neurocognitive impairments in later life. In summary, increased sex-specific vigilance is required in countries with high ZIKV prevalence, where impaired neurodevelopment may be camouflaged by a healthy appearance at birth.Male offspring of pregnant mice infected with a low dose of Zika virus infection have increased testosterone levels, an increased number of immature neurons in apical hippocampal dendrites and are less likely to survive in utero infection than female littermates.
DNP - Der Neurologe & Psychiater | 2017
Sibylle C. Hodecker; Manuel A. Friese
ZusammenfassungDie für die schubförmige Multiple Sklerose (MS) zugelassenen immunmodulierenden und -supprimierenden Therapien zeigen bei der chronisch-progredienten Verlaufsform wenig oder keine Wirksamkeit. Die niedrige Wirksamkeit antientzündlicher Wirkstoffe in der Therapie der chronisch-progredienten MS im Vergleich zur schubförmig-remittierenden MS ist vermutlich durch die unterschiedliche Akzentuierung pathogenetischer Veränderungen der Verlaufsformen begründet.